Brown & Brown, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$1.08B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BRO stock price vs EG: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at EG's multiple
Needs EG P/E.
Implied fair value · at BRO's multiple
Needs BRO P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BROWN & BROWN, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
EVEREST GROUP, LTD. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MARSH & MCLENNAN COMPANIES, INC.
BRO vs MMC
Arthur J. Gallagher & Co.
BRO vs AJG
Hub Group, Inc.
BRO vs HUBG
Aon plc
BRO vs AON
HANOVER INSURANCE GROUP, INC.
BRO vs THG
REINSURANCE GROUP OF AMERICA INC
BRO vs RGA
TRAVELERS COMPANIES, INC.
BRO vs TRV
RENAISSANCERE HOLDINGS LTD
BRO vs RNR
ARCH CAPITAL GROUP LTD.
BRO vs ACGL
MARKEL GROUP INC.
BRO vs MKL
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe BRO's superior margins and 22.8% revenue growth will persist and justify a sustained premium, then hold or selectively add exposure; otherwise, sell or avoid because reversion toward EG-like multiples (P/E ~9.0x) implies an implied price of $28.53 (~57% downside) based on the provided EG comparison.
BRO trades at a substantial premium to EG on multiples (P/E, P/S, EV/EBITDA), producing an implied price ($28.53) that is ~57% below the current $66.54. The gap largely reflects market willingness to pay for BRO's superior margins and growth, but if investors re-rate toward EG's multiples the downside is large.
Supporting Metrics